Capecitabine

CAS 154361-50-9

Also known as: Xeloda Ro091978 R340

Capecitabine is an antimetabolic fluorodeoxynucleoside carbamate drug that can be converted into 5-FU in vivo. It is developed by Roche company and trade name is Xeloda. It can inhibit cell division and interfere with RNA and protein synthesis. It is suitable for the further treatment of paclitaxel and advanced primary or metastatic breast cancer, including anthracycline antibiotic chemotherapy. It is mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.

Request a Quote
Category: Pharmaceutical Chemicals APISubcategory: Antineoplastic Drugs APIProduct ID: capecitabine-154361-50-9
Payment & Shipping Terms Supply Capacity
Payment Terms: T/T, WU Production Capacity: 1000kg/year
Min. Order: 1 Gram Packing: according to the customer's requirements
Means of Transport: Ocean, Air, Land Delivery Date: 7 days

Capecitabine

CAS 154361-50-9

Capecitabine is an antimetabolic fluorodeoxynucleoside carbamate drug that can be converted into 5-FU in vivo. It is developed by Roche company and trade name is Xeloda. It can inhibit cell division and interfere with RNA and protein synthesis. It is suitable for the further treatment of paclitaxel and advanced primary or metastatic breast cancer, including anthracycline antibiotic chemotherapy. It is mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.

We can customize according to customer's requirement

if you have any question pls mail us or call us.

CAS Number 154361-50-9
Molecular Formula C9H12FN3O4
Molecular Weight 245.2077
Place of Origin Shandong,China (Mainland)
Brand Name MOSINTER
CAS No. 154361-50-9
Purity 99% MIN
Request a quote

Send an inquiry for Capecitabine

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP